ConductScience.org, home

Paper22160036

Genetic and epigenetic complexity in myeloproliferative neoplasms.

Cross NC. Hematology Am Soc Hematol Educ Program, 2011. Cited by 89 papers, by iCite.

Cite this record

ConductScience Library. Genetic and epigenetic complexity in myeloproliferative neoplasms. Papers, record 22160036. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22160036

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetic and epigenetic complexity in myeloproliferative neoplasms.
PubMed
Journal
Hematology Am Soc Hematol Educ Program
PubMed
Year
2011
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
2.32
iCite
Revised in PubMed
2016-10-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cross NCNicholas C P

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone Marrow NeoplasmsMajor topic
Epigenesis, GeneticMajor topic
Myeloproliferative DisordersMajor topic
Genetic Predisposition to Disease
Genomic Instability
Humans
Janus Kinase 2

Source PubMed

Download CSV of topics

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
38585044Laboratory-developed Droplet Digital PCR Assay for Quantification of the JAK2 V617F Mutation.Glob Med Genet2024https://conductscience.org/library/papers/38585044PubMed
38310350Detecting Multiple Driver Mutations in a Patient with Essential Thrombocythemia.Am J Case Rep2024https://conductscience.org/library/papers/38310350PubMed
34631089Hereditary hemochromatosis and JAK2-positive polycythemia vera.Clin Case Rep2021https://conductscience.org/library/papers/34631089PubMed
33639674Frequency of Zygosity in Jak-2 Positive Patients with Polycythemia Vera-Pakistan's Perspective.Asian Pac J Cancer Prev2021https://conductscience.org/library/papers/33639674PubMed
31106152The Role of New Technologies in Myeloproliferative Neoplasms.Front Oncol2019https://conductscience.org/library/papers/31106152PubMed
30899467When hemolysis masks polycythemia vera.Clin Case Rep2019https://conductscience.org/library/papers/30899467PubMed
30828140Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes: Molecular Pathogenetic Mechanisms and Their Implications.Indian J Hematol Blood Transfus2019https://conductscience.org/library/papers/30828140PubMed
30765477SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA.Haematologica2019https://conductscience.org/library/papers/30765477PubMed
30056580A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs.Ann Hematol2018https://conductscience.org/library/papers/30056580PubMed
29650953HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.Nat Commun2018https://conductscience.org/library/papers/29650953PubMed
29562644Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.Int J Mol Sci2018https://conductscience.org/library/papers/29562644PubMed
29235894Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia.Future Oncol2018https://conductscience.org/library/papers/29235894PubMed
29085634Prevalence of the Janus kinase 2 V617F mutation in Philadelphia-negative myeloproliferative neoplasms in a Portuguese population.Biomed Rep2017https://conductscience.org/library/papers/29085634PubMed
28859112Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.PLoS One2017https://conductscience.org/library/papers/28859112PubMed
28827411Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results.Blood2017https://conductscience.org/library/papers/28827411PubMed
27756071Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review.Med Princ Pract2016https://conductscience.org/library/papers/27756071PubMed
27648344Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors.J Adv Pract Oncol2015https://conductscience.org/library/papers/27648344PubMed
27570458Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned.Onco Targets Ther2016https://conductscience.org/library/papers/27570458PubMed
27567907Ruxolitinib dose management as a key to long-term treatment success.Int J Hematol2016https://conductscience.org/library/papers/27567907PubMed
27341078A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells.Blood Cancer J2016https://conductscience.org/library/papers/27341078PubMed

See all 44 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22160036

GET https://conductscience.org/api/papers/v1/22160036/cited_by?page=2